Sanjivani Paranteral [SANJIVIN] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanjivani Paranteral wins in 7 metrics, Divi's Laboratories wins in 11 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSanjivani ParanteralDivi's LaboratoriesBetter
P/E Ratio (TTM)32.2470.87Sanjivani Paranteral
Price-to-Book Ratio6.7110.91Sanjivani Paranteral
Debt-to-Equity Ratio20.420.03Divi's Laboratories
PEG RatioN/A2.68N/A
EV/EBITDA24.8451.06Sanjivani Paranteral
Profit Margin (TTM)11.34%23.89%Divi's Laboratories
Operating Margin (TTM)13.88%25.60%Divi's Laboratories
EBITDA Margin (TTM)13.88%25.60%Divi's Laboratories
Return on Equity20.30%14.64%Sanjivani Paranteral
Return on Assets (TTM)10.35%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-179.46M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-27.22%26.68%Divi's Laboratories
Price-to-Sales Ratio (TTM)3.6916.92Sanjivani Paranteral
Enterprise Value$2.62B$1,565.01BDivi's Laboratories
EV/Revenue Ratio3.6616.21Sanjivani Paranteral
Gross Profit Margin (TTM)48.33%60.33%Divi's Laboratories
Revenue per Share (TTM)$61$363Divi's Laboratories
Earnings per Share (Diluted)$6.66$86.80Divi's Laboratories
Beta (Stock Volatility)-0.820.27Sanjivani Paranteral
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Sanjivani Paranteral vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sanjivani Paranteral-2.19%-1.12%-11.65%-2.46%-25.72%-44.39%
Divi's Laboratories2.05%-0.21%-6.98%-5.91%7.87%1.29%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sanjivani Paranteral-27.22%333.27%2,293.46%994.33%366.08%143.88%
Divi's Laboratories26.68%71.47%87.96%447.34%1,551.94%8,332.49%

Performance & Financial Health Analysis: Sanjivani Paranteral vs Divi's Laboratories

MetricSANJIVINDIVISLAB
Market Information
Market Cap i₹2.64B₹1.63T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i3,528455,358
90 Day Avg. Volume i7,954389,068
Last Close₹212.30₹6,151.50
52 Week Range₹203.10 - ₹396.95₹4,828.95 - ₹7,071.50
% from 52W High-46.52%-13.01%
All-Time High₹396.95 (Dec 30, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-46.52%-13.01%
Growth Metrics
Quarterly Revenue Growth0.09%0.14%
Quarterly Earnings Growth0.01%0.27%
Financial Health
Profit Margin (TTM) i0.11%0.24%
Operating Margin (TTM) i0.14%0.26%
Return on Equity (TTM) i0.20%0.15%
Debt to Equity (MRQ) i20.420.03
Cash & Liquidity
Book Value per Share (MRQ)₹31.98₹563.87
Cash per Share (MRQ)₹2.04₹132.86
Operating Cash Flow (TTM) i₹35.93M₹19.67B
Levered Free Cash Flow (TTM) i₹80.94M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Sanjivani Paranteral vs Divi's Laboratories

MetricSANJIVINDIVISLAB
Price Ratios
P/E Ratio (TTM) i32.2470.87
Forward P/E iN/A109.26
PEG Ratio iN/A2.68
Price to Sales (TTM) i3.6916.92
Price to Book (MRQ) i6.7110.91
Market Capitalization
Market Capitalization i₹2.64B₹1.63T
Enterprise Value i₹2.62B₹1.57T
Enterprise Value Metrics
Enterprise to Revenue i3.6616.21
Enterprise to EBITDA i24.8451.06
Risk & Other Metrics
Beta i-0.820.27
Book Value per Share (MRQ) i₹31.98₹563.87

Financial Statements Comparison: Sanjivani Paranteral vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SANJIVINDIVISLAB
Revenue/Sales i₹178.92M₹24.10B
Cost of Goods Sold i₹111.14M₹9.56B
Gross Profit i₹67.78M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹24.84M₹6.17B
EBITDA i₹26.83M₹8.48B
Pre-Tax Income i₹23.01M₹7.33B
Income Tax i₹5.70M₹1.88B
Net Income (Profit) i₹17.31M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SANJIVINDIVISLAB
Cash & Equivalents i₹14.85M₹4.15B
Total Current Assets i₹341.80M₹100.81B
Total Current Liabilities i₹317.92M₹14.52B
Long-Term Debt i₹52.89M₹20.00M
Total Shareholders Equity i₹398.71M₹149.69B
Retained Earnings iN/A₹134.00B
Property, Plant & Equipment i₹205.64M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SANJIVINDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSANJIVINDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,528455,358
Average Daily Volume (90 Day) i7,954389,068
Shares Outstanding i11.88M265.47M
Float Shares i5.73M120.74M
% Held by Insiders i0.55%0.52%
% Held by Institutions i0.01%0.29%

Dividend Analysis & Yield Comparison: Sanjivani Paranteral vs Divi's Laboratories

MetricSANJIVINDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025